Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Diabetes

Predicting renal function decline in patients with T2DM

A recent cohort study has shown that cardiac autonomic neuropathy (CAN) is associated with increased albuminuria and decreased estimated glomerular filtration rate (eGFR) at baseline and is predictive of a subsequent decline in eGFR. Could CAN be used to identify patients who are at increased risk of early decline in eGFR?

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Tahrani, A. A. et al. Cardiac autonomic neuropathy predicts renal function decline in patients with type 2 diabetes: a cohort study. Diabetologia 57, 1249–1256 (2014).

    Article  CAS  Google Scholar 

  2. Vinik, A. I. & Ziegler, D. Diabetic cardiovascular autonomic neuropathy. Circulation 115, 387–397 (2007).

    Article  Google Scholar 

  3. Nasrallah, M. P. & Ziyadeh, F. N. Overview of the physiology and pathophysiology of leptin with special emphasis on its role in the kidney. Semin. Nephrol. 33, 54–65 (2013).

    Article  CAS  Google Scholar 

  4. Sundkvist, G. & Lilja, B. Autonomic neuropathy predicts deterioration in glomerular filtration rate in patients with IDDM. Diabetes Care 16, 773–779 (1993).

    Article  CAS  Google Scholar 

  5. Astrup, A. S. et al. Cardiac autonomic neuropathy predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy. Diabetes Care 29, 334–339 (2006).

    Article  Google Scholar 

  6. Kim, Y. K. et al. Cardiac autonomic neuropathy as a predictor of deterioration of the renal function in normoalbuminuric, normotensive patients with type 2 diabetes mellitus. J. Korean Med. Sci. 24 (Suppl.), S69–S74 (2009).

    Article  CAS  Google Scholar 

  7. Gulichsen, E., Fleischer, J., Ejskjaer, N., Eldrup, E. & Tarnow, L. Screening for diabetic cardiac autonomic neuropathy using a new handheld device. J. Diabetes Sci. Technol. 6, 965–972 (2012).

    Article  Google Scholar 

  8. Dimitropoulos, G., Tahrani, A. A. & Stevens, M. J. Cardiac autonomic neuropathy in patients with diabetes mellitus. World J. Diabetes 5, 17–39 (2014).

    Article  Google Scholar 

  9. [No authors listed] The effect of intensive diabetes therapy on the development and progression of neuropathy. The Diabetes Control and Complications Trial Research Group. Ann. Intern. Med. 122, 561–568 (1995).

  10. Gaede, P., Vedel, P., Parving, H. H. & Pedersen, O. Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study. Lancet 353, 617–622 (1999).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to George Jerums.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jerums, G., MacIsaac, R. Predicting renal function decline in patients with T2DM. Nat Rev Endocrinol 10, 381–382 (2014). https://doi.org/10.1038/nrendo.2014.75

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrendo.2014.75

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing